Connect with us

Cannabis

Colorado Marijuana Posts Record $1.5 Billion Performance

Published

on

Legal cannabis sales in the Centennial State Rose up to $1.5 billion, in a metric that encompasses both medical and recreational cannabis markets. The data was released to the public by the State‘s Department of Revenue.The closing number for 2016 was $1.3 billion in sales which, at the time, also set a record. The comparison of performances shows the state‘s sales have experienced a 15% rise year-on-year. In 2015, $996.5 million in sales were registered.

At the start of 2017, even with dwindling marijuana prices that had dropped 33%, the state had already started to set monthly records for sales, which ultimately led to the bar-setting performance for the sector by the end of the annum.

A breakdown of the numbers shows us that adult recreational use rose to $1.09 billion over the year. The remaining $416.5 million came from the medical marijuana sector.

Last year, Colorado needed only eight months to break the $1 billion sales threshold — yet another record-breaking performance. It took the state 10 months over the prior year to reach the number.

The addition of PTSD to the list of treatable conditions served as a boost for the sales of MMJ back in June of last year.

Ruben is a South American writer who focuses on the state of the cryptocurrency, cannabis and tech industries worldwide.

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Cannabis

Medicine Man Technologies: Showing Cannabis Companies How It’s Done

Published

on

2018 brought us legal recreational marijuana throughout Canada, legalization of medical cannabis in New Zealand, de-scheduling of industrial hemp in the U.S. via the Farm Bill, more U.S. states legalizing medical (now 33 in total plus D.C.) and recreational (10 states plus D.C.) cannabis and much more that further legitimized the industry.  According to the latest Gallup Poll, two in three Americans now supports legalizing marijuana, the highest level ever for advocacy.

It seems that the tailwinds for the industry continue to blow mightily.  With this rapid growth, companies worldwide are looking to get a piece of the burgeoning market.  As many have found out in recent years, though, it isn’t as simple as just putting some seeds in a row of planters.  It’s big business that will get much, much bigger and it takes a great deal of knowledge and experience to avoid what could be disastrous pitfalls to upstarts.

From its headquarters in Denver, Colorado, Medicine Man Technologies (OTCQX: MDCL) is there to provide consult for companies across a full menu of topics.  A la cart or comprehensive services are offered depending on exactly what the client needs, covering everything from obtaining a license to standard operating procedure for handling a retail customer and everywhere in between.  For some, the company has come in and effectively turned-around a stumbling grow operation with its program called “Cultivation MAX.”  With this program, the company looks to replicate its own grow success, showing the client the intricacies necessary to have a repeatable, successful harvests.

To help with that matter, the company offers Success Nutrients®, a nine-product nutrient line with the needed ingredients to simultaneously maximize per-foot flower yield and growth of the highest quality flowers.

The company has deep experience throughout the entire supply chain, including parent company, Medicine Man Denver, being the largest cultivation/retail facility in Colorado.  The parent company has been operating in the cannabis industry for a number of years, amassing the intellectual property, technology and experience to help others achieve success.  To that end, Medicine Man Technologies operates in several capacities, namely licensing its technology and operating as a cannabis consulting outfit, with investors, legal and licensed commercial cultivation and dispensary operators and new companies looking to participate in the cannabis industry.

The company works with, or has worked with, clients in California, Iowa, Oregon, Colorado, Nevada, Illinois, Michigan, Arkansas, Pennsylvania, Florida, Ohio, Maryland, New York, Oklahoma, Massachusetts, Puerto Rico, Canada, Australia, Germany, and South Africa.   Last summer, Medicine Man Technologies granted Canada House Wellness Group (CSE: CHV) exclusive licensing rights to its IP and products lines (Three a Light® and Success Nutrients®) for the Canadian marketplace, along with assignment of an existing Cultvation MAX agreement to Canada House in exchange for an initial payment of C$4.65 million in cash and stock and future fees based on revenue in Canada.

The Master License Agreement was a boon to the company’s financial performance in the quarter ended September 30, 2018 and for the year-to-date figures, with total income from January through September totaling $9.92 million and net profit coming in at $5.16 million, or 19 cents per share.  It’s worth noting that while the license agreement certainly was material, organic growth was strong also.  For the nine-month period, organic revenue was $3.78 million, up from $2.49 million in the year prior period.

These developments, along with a new Chief Operating Officer, Joe Puglise – the former President of New York properties for iHeartMedia – and what looks to be a general revitalization of so-called pot stocks recently, should have the investment community watching for what the market has to offer in 2019 and the continued evolution of Medicine Man Technologies.

Online Media Group, Inc. is not registered with any financial or securities regulatory authority and holds no investment licenses and does not provide, nor claims to provide, investment advice. We are a publisher of original and third party news and information. This article is sponsored content and is neither an offer nor recommendation to buy, sell or hold any security. The views expressed are our own and not intended to be the basis for any investment decision. Investing intrinsically involves substantial risk and readers are reminded to consult an investment professional and complete their own due diligence, including SEC filings, when researching any companies mentioned in this release. This release is based upon publicly available information and, while vetted, is not considered to be all-inclusive or guaranteed to be free from errors. With respect to Section 17(B) of the Securities Act of 1933 and in the interest of full disclosure, we call the reader’s attention to the fact that Online Media Group, Inc. received $1,333 in compensation from IRTH Communications for content creation, advertising and distribution services related to this material.

Continue Reading

Cannabis

Backstopped by Science, CBD Unlimited Aiming for 30,000 Distribution Points

Published

on

2018 was a year of milestones for the cannabis markets, including Canada becoming the first Group of Seven country to legalize recreational use and the number of U.S. states where medical or recreational marijuana is legal rising to 33 and 10, respectively, along with the District of Columbia.  A watershed moment happened in the industrial hemp space too, with the passage of the U.S. Farm Bill 2018 removing the plant from the federal controlled substance list, effectively making it a legal agricultural commodity as of the start of 2019.

Hemp is a variety of the cannabis sativa plant that does not contain any meaningful levels of THC (tetrahydrocannabinol), the marijuana component responsible for the psychotropic high.  What it does contain is CBD (cannabidiol), a non-intoxicating compound of cannabis that is widely trumpeted for a litany of therapeutic benefits, including reducing pain, nausea, anxiety and inflammation.

The legalization of industrial hemp will certainly make CBD one of the most active areas within the broader cannabis markets in 2019.

As noted by CBD Unlimited (OTC: EDXC) Chairman and CEO Todd Davis in a recent interview with SNNLive, sourcing is something that consumers need to be aware of because there will be a battery of companies jumping on the bandwagon to sell something that is hot.  Eventually, the Farm Bill will help correct any supply/demand imbalance, at which time quality of product will again move to the foreground.

CBD Unlimited has been a pioneer in the CBD space, building its portfolio of products on science, science that shows CBD attaches to the CB2 receptor.  The CB2 receptor is distributed throughout the entire body of humans and animals.  By attaching to the CB2 receptor, CBD activates a channel that alleviates or stops pain without unpleasant side effects.

The company offers an array of CBD products for both people and their pets.  The product lineup includes oils, concentrates, topicals, beverages and – for dogs and cats – Phyto-Bites CBD soft chews.  Because the company specifically extracts and isolates only the CBD molecule from industrial hemp, their products are legal in all 50 states.

While there is a broad spectrum of applications, the company’s target market is adults over age 50 in a state of chronic inflammation and pain that are looking for a natural solution without the risks associated with pharmaceutical drugs.

Davis keeps CBD in perspective, viewing it not a miracle cure that is a replacement for everything, but as a support mechanism that is changing the quality of life for many people.  His company has kept the business model simple (in a manner of speaking), taking a molecule that is known to have remarkable therapeutic benefits and turning it into something that everyday people can use and doctors can adopt into their practices.

Against the backdrop of a favorable consumer environment, the growth driver for CBD Unlimited is distribution.   A pilot program pushed the company over its first target of 1,000 distribution points in 2018.  To help with the initiative to reach 5,000 distribution points in 2019, Davis recruited Dustin Sullivan as Chief Operating Officer.  Sullivan brings his experience from 18 years at Walgreens where he trained and work with people throughout the big box pharmacy business.  Sullivan’s expertise has resulted in the company getting in front of the biggest buyers in the U.S. as part of the 2019 target and next milestone of at least 30,000 distribution points in the next one-two years.

Online Media Group, Inc. is not registered with any financial or securities regulatory authority and holds no investment licenses and does not provide, nor claims to provide, investment advice. We are a publisher of original and third party news and information. This article is sponsored content and is neither an offer nor recommendation to buy, sell or hold any security. The views expressed are our own and not intended to be the basis for any investment decision. Investing intrinsically involves substantial risk and readers are reminded to consult an investment professional and complete their own due diligence, including SEC filings, when researching any companies mentioned in this release. This release is based upon publicly available information and, while vetted, is not considered to be all-inclusive or guaranteed to be free from errors. With respect to Section 17(B) of the Securities Act of 1933 and in the interest of full disclosure, we call the reader’s attention to the fact that Online Media Group, Inc. received $1,333 in compensation from IRTH Communications for content creation, advertising and distribution services related to this material. style���

Continue Reading

Breaking

A New Spin on CBD: Quanta Upping the Game with Bioenergy

Published

on

Cannabidiol, or CBD for short, a component of cannabis, is all the rage today, underscored by President Trump last week signing the U.S. Farm Bill 2018 into law. After decades of being held to the same standard as cannabis that contains THC, hemp is finally removed from the Controlled Substance Act, effectively making hemp-based CBD legal at the federal level.

Cannabis and hemp are similar with one major differentiator: THC (tetrahydrocannabinol), the cannabinoid in cannabis responsible for the psychoactive high, or “stoned” feeling from ingesting marijuana. Hemp contains little to no THC, but does contain CBD, a non-psychotropic cannabinoid widely acclaimed for a litany of medical uses, including applications for hard-to-treat diseases like epilepsy and PTSD, as well as more casual uses, such as skincare.

With the passage of the Farm Bill, hemp-based CBD – which still falls under the regulatory scrutiny of the U.S. Food and Drug Administration – is legal for a bevy of development activity.

The scientists at Quanta (OTC: QNTA) are putting a new spin on cannabinoids, specifically CBD, amplifying the benefits by using the combination of quantum physics and biochemistry to increase bioenergy within the cell. As explained in a corporate video, this produces a better chemical reaction in the body.

The science is based in part on principles of quantum physics proving that everything in the universe is energy and has its own vibration, or vibrational frequency more specifically, including cannabinoid receptors. Cannabis, by virtue of its properties as a plant, is losing vibrational power every day. Quanta uses a patented technology to retrain the vibrations within cannabinoids, which raises their bioenergy, until they have identical frequencies to the body’s cannabinoid receptors.

When these matching frequencies combine, the highest possible response is the result and the CBD is absorbed into the body more efficiently with little to no side effect. This takes each element in Quanta’s formula to peaks levels of performance, meaning the user enjoys a better experience in reduction of things like pain, inflammation, stiffness and anxiety that CBD is heralded for delivering.

Quanta’s lead product is CBD Muscle Rub, a combination of 13 natural elements including turmeric, arnica and polarized CBD, administered topically for the relief of muscle and joint pain and stiffness.

While the initial focus is on hemp-based CBD, the technology is available for licensing or product development that can be applied to all types of plant matter to enhance energy in naturally occurring molecules utilizing the same properties of the Law of Vibration and the fact that humans are bio-electric beings. In addition to the effect on muscles and joints, the complete Quanta process, which involves identifying natural elements by their frequency and using magnetic and electric frequencies to illicit changes at the sub-atomic level to make the

targeted molecules move faster to create a bond in receptors for an energized and frictionless experience, have been shown to significantly reduce anxiety, paranoia, cognitive haze and drowsiness.

Online Media Group, Inc. is not registered with any financial or securities regulatory authority and holds no investment licenses and does not provide, nor claims to provide, investment advice. We are a publisher of original and third party news and information. This article is sponsored content and is neither an offer nor recommendation to buy, sell or hold any security. The views expressed are our own and not intended to be the basis for any investment decision. Investing intrinsically involves substantial risk and readers are reminded to consult an investment professional and complete their own due diligence, including SEC filings, when researching any companies mentioned in this release. This release is based upon publicly available information and, while vetted, is not considered to be all-inclusive or guaranteed to be free from errors. With respect to Section 17(B) of the Securities Act of 1933 and in the interest of full disclosure, we call the reader’s attention to the fact that Online Media Group, Inc. received $1,333 in compensation from IRTH Communications for content creation, advertising and distribution services related to this material.

Continue Reading

Most Popular